THE CHARLES STARK DRAPER LABORATORY, INC. - ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMALL INTESTINE-IMMUNE ORGAN-ON-CHIP MODELS, MOLECULAR ASSAYS, OMICS-BASED TECHNOLOGIES, ADVANCED ANALYTICAL METHODS FOR BIOMARKER DISC

On Dec 17, 2025, Department of Health and Human Services obligated $36,040,491.05 to THE CHARLES STARK DRAPER LABORATORY, INC. for advance the development of a medical countermeasure (mcm) evaluation platform that consists of vascular-immune and small intestine-immune organ-on-chip models, molecular assays, omics-based technologi…. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in CAMBRIDGE, MA. The contract is scheduled through Sep 28, 2028. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.